Product Program year 2025 Source: CMS Open Payments

Vitek2

Device Diagnostics

PDI 03573026147167

Open in the dashboard

General payments

$16,475

50 payments

Research payments

$705,666

66 payments

Through program year 2025, $16,475 in general payments and $705,666 in research payments were reported against Vitek2 (Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $406 13
2025 Research $66,834 8
2024 General $826 27
2024 Research $637,918 52
2023 General $15,243 10
2023 Research $913 6

Breakdown

Who paid General payments · program years 2023–2025
  1. bioMerieux $16,475 50 payments
Top recipients General payments · program year 2025
  1. Dena Shibib Anatomic Pathology & Clinical Pathology · Oklahoma City, OK $103 25% · 2 payments
  2. Hai Nguyen-Tran Pediatric Infectious Diseases · Aurora, CO $65 16% · 1 payment
  3. Raul Benavides Clinical Pathology/Laboratory Medicine · Dallas, TX $52 13% · 1 payment
  4. Micah Bhatti Pediatric Infectious Diseases · Houston, TX $39 10% · 1 payment
  5. Ping Chi Medical Oncology · New York, NY $23 6% · 1 payment

The top 5 of 12 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Anatomic Pathology & Clinical Pathology Pathology $141 35% · 3 practitioners
  2. Pediatric Infectious Diseases Pediatrics $104 26% · 2 practitioners
  3. Clinical Pathology/Laboratory Medicine Pathology $52 13% · 1 practitioner
  4. Emergency Medicine $23 6% · 1 practitioner
  5. Medical Oncology Internal Medicine $23 6% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $111 27% · 3 recipients
  2. Oklahoma $103 25% · 1 recipient
  3. Colorado $65 16% · 1 recipient
  4. New York $46 11% · 2 recipients
  5. Idaho $20 5% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

50 general · 66 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record